Manka, Szymon W. http://orcid.org/0000-0001-6733-146X
Zhang, Wenjuan http://orcid.org/0000-0002-3011-9956
Wenborn, Adam
Betts, Jemma
Joiner, Susan
Saibil, Helen R. http://orcid.org/0000-0002-2266-8891
Collinge, John http://orcid.org/0000-0003-2220-7566
Wadsworth, Jonathan D. F. http://orcid.org/0000-0002-4797-2259
Funding for this research was provided by:
Wellcome Trust (202679/Z/16/Z, 206166/Z/17/Z, 106249/Z/14/Z)
RCUK | Medical Research Council (MC_U12316055, MC_UU_00024/5)
Article History
Received: 6 January 2022
Accepted: 27 April 2022
First Online: 13 July 2022
Competing interests
: J.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination, and therapeutics. D-Gen supplied the ICSM35 and ICSM18 antibodies used for western blot and ELISA performed in this study. The other authors declare no competing interests.